about
Mechanisms of chemotherapy-induced behavioral toxicitiesNeuropathic cancer pain: What we are dealing with? How to manage it?Animal models of peripheral neuropathiesAssessment of paclitaxel induced sensory polyneuropathy with "Catwalk" automated gait analysis in miceNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewAnti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppressionA novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathySensory neuronopathies.Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trialA model of toxic neuropathy in Drosophila reveals a role for MORN4 in promoting axonal degenerationRisk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like ChemotherapyA phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsBasic science and clinical management of painful and non-painful chemotherapy-related neuropathy.An automated climbing apparatus to measure chemotherapy-induced neurotoxicity in Drosophila melanogaster.Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in miceDevelopment of TRPM8 Antagonists to Treat Chronic Pain and Migraine.Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathyConsiderations for Training Cancer SurvivorsChronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalSensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons.Therapeutic strategies for cancer treatment related peripheral neuropathies.Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.Neurovascular function and sudorimetry in health and disease.Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in miceConducting cancer control and survivorship research via cooperative groups: a report from the American Society of Preventive Oncology.Impairments that influence physical function among survivors of childhood cancerDrosophila melanogaster: a new model to study cisplatin-induced neurotoxicity.Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms MacroglobulinemiaCandidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathyActive video games to promote physical activity in children with cancer: a randomized clinical trial with follow-up.Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathyMitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.
P2860
Q26998870-9FF91A0F-B8BA-4095-B968-D5C36F027F69Q26998945-3D84A09D-D4EE-4DCC-B408-D375CA69D959Q27028046-39E623C9-17B3-40F1-80A6-F2B1BBE82E6FQ27304576-B1063D41-808D-4C17-B3B9-B5B017CAB48EQ28270819-B376DAAB-8E21-4DF9-A042-B16F0A245C1CQ28468568-650A3AB8-E7A9-43A7-ACED-A513289EEAC5Q28484947-ABC61393-E341-44E7-8BEA-CA5A5256AD9BQ30278525-B835B491-5F72-40DD-95F5-70DAC100608DQ30818191-DF621E42-BA37-4892-A97A-3A361CFB04ECQ31050387-9973F07F-FF93-426B-877C-8108B4C54BF0Q33112264-F1BCDD0A-5B66-4841-B532-A7E97D7E1803Q33688318-594A61CC-9FD5-4142-99A7-0BFC63042E51Q33693343-08A008EC-03B2-4F2E-A2DD-2B3326EF15E6Q33711666-04B59F57-2E25-40F7-882A-4048F8CD8ACFQ33728158-FE5AE24C-B12D-4B36-965B-CF483B1FF11BQ33764113-346B752D-B328-4765-8409-317C3EBCF488Q33851503-CDE90D72-3E19-4708-B2C6-BA8F84F0AD56Q34038073-3CB6D3EE-3B28-4697-AD9D-572087999293Q34133825-35AEA1B8-EFEF-4848-A695-9BDAF8399BFFQ34285948-3697EFCF-B716-40DC-94E2-431EE915283FQ34403197-FB40EA8F-82FB-447C-B362-20F4F7B11FA3Q34412078-45D6618F-4CFB-4FCB-B708-476B21D4A4D2Q34433406-E815478D-A2E5-4D4A-B09B-AF51E21EB465Q34653461-D75F1BE1-628B-4EB2-984C-CCF152700B6FQ34726851-98CD4438-C838-47E2-9B7B-2701CBE2C339Q34866427-AE1F1CA0-7C40-4102-9888-D2CE2893121FQ34917256-B126C634-5350-4976-9634-56E46BE6B1F5Q35019148-42EEBBBE-C594-45F8-AF2D-B75ED293373BQ35072010-57A39F77-E470-4137-90AC-5E32D095CDFAQ35082766-5F98ECD8-8B87-4BB3-AA81-A5E07D0A9305Q35090211-9E48748C-69E7-48E2-9719-64F61C7C227FQ35097338-6CA13870-9D98-402C-BF05-A6FB05019A31Q35100937-E6508B39-F1A3-4DB8-A74A-D61944DAF7DBQ35134836-DA3B889B-FE6F-4F02-9152-6B4F8CEF0DC1Q35141325-364A5BEA-18C9-419D-9F45-14E403EFEE5CQ35248852-DE65BDF2-658F-4FAA-AACF-9FCF5131E1BDQ35248891-0E8A7D0C-4E13-4FA8-A47F-727806A269A3Q35613627-A1CA4560-51CE-4FF8-864C-9826A495C649Q35642335-2E0AD69D-BEC1-4505-A0BF-8EC960B78046Q35721076-6084C815-66A6-47D2-B214-A477148C2181
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chemotherapy-induced neuropathy.
@ast
Chemotherapy-induced neuropathy.
@en
Chemotherapy-induced neuropathy.
@nl
type
label
Chemotherapy-induced neuropathy.
@ast
Chemotherapy-induced neuropathy.
@en
Chemotherapy-induced neuropathy.
@nl
prefLabel
Chemotherapy-induced neuropathy.
@ast
Chemotherapy-induced neuropathy.
@en
Chemotherapy-induced neuropathy.
@nl
P1476
Chemotherapy-induced neuropathy.
@en
P2093
Anthony J Windebank
Wolfgang Grisold
P356
10.1111/J.1529-8027.2008.00156.X
P577
2008-03-01T00:00:00Z